IDO1 and neoplasm: By contrast, the host IDO/TDO-mediated kynurenine pathway contributes to immunosuppression by driving regulatory T-cell differentiation and effector T-cell exhaustion, thereby fostering tumor immune evasion and presenting a “double-edged sword” effect (64).